Literature DB >> 11162490

Functionally conserved xenobiotic responsive enhancer in cytochrome P450 3A7.

G Bertilsson1, A Berkenstam, P Blomquist.   

Abstract

Nuclear receptors CAR and PXR play a key role in cytochrome P450 gene induction by xenobiotics. Human cytochrome P450 3A7 (CYP3A7) is expressed from early in gestation until the perinatal period, when there is a switch in expression to CYP3A4. Here we demonstrate that a PXR and CAR responsive enhancer is located approximately 8 kb upstream of the proximal CYP3A7 promoter. This distal xenobiotic responsive enhancer module (XREM) is conserved with the XREM of CYP3A4. Interestingly, not only the XREM, but also the entire promoters exhibit 90% sequence identity up to -8.8 kb, indicating a close evolutionary distance. We propose that the promoters have coevolved to functionally conserve P450 gene induction in response to xenobiotics through CAR and PXR. Thus, nuclear receptors for xenobiotics may not only play a role to provide a survival advantage during adulthood, but also to protect the embryo against endogenous and exogenous toxins. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162490     DOI: 10.1006/bbrc.2000.4066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 2.  Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds.

Authors:  E J Reschly; Matthew D Krasowski
Journal:  Curr Drug Metab       Date:  2006-05       Impact factor: 3.731

Review 3.  Significance of the minor cytochrome P450 3A isoforms.

Authors:  Ann K Daly
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 4.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

Review 5.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

Review 6.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

7.  Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort.

Authors:  Ute Gödtel-Armbrust; Annegret Metzger; Ulrike Kroll; Olaf Kelber; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-26       Impact factor: 3.195

8.  Genome-wide discovery of drug-dependent human liver regulatory elements.

Authors:  Robin P Smith; Walter L Eckalbar; Kari M Morrissey; Marcelo R Luizon; Thomas J Hoffmann; Xuefeng Sun; Stacy L Jones; Shelley Force Aldred; Anuradha Ramamoorthy; Zeruesenay Desta; Yunlong Liu; Todd C Skaar; Nathan D Trinklein; Kathleen M Giacomini; Nadav Ahituv
Journal:  PLoS Genet       Date:  2014-10-02       Impact factor: 5.917

9.  Guide to the Assessment of Mature Liver Gene Expression in Stem Cell-Derived Hepatocytes.

Authors:  Mihaela Zabulica; Raghuraman C Srinivasan; Massoud Vosough; Christina Hammarstedt; Tingting Wu; Roberto Gramignoli; Ewa Ellis; Kristina Kannisto; Alexandra Collin de l'Hortet; Kazuki Takeishi; Alejandro Soto-Gutierrez; Stephen C Strom
Journal:  Stem Cells Dev       Date:  2019-07-15       Impact factor: 3.272

10.  Dual-color fluorescence imaging to monitor CYP3A4 and CYP3A7 expression in human hepatic carcinoma HepG2 and HepaRG cells.

Authors:  Saori Tsuji; Fumihiko Kawamura; Musashi Kubiura; Ayaka Hayashi; Tetsuya Ohbayashi; Yasuhiro Kazuki; Christophe Chesné; Mitsuo Oshimura; Masako Tada
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.